CMV

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Letermovir vs Valganciclovir in CMV R+ Kidney Transplant

Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

Letermovir for CMV Prevention After Lung Transplantation

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy

Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol

CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant

Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals